Recent developments in healthcare include new FDA approvals for diabetes and eye treatments, alongside policy debates and updates in public health screening and research.

A physicians' group has filed a lawsuit seeking to withdraw the 2025-2030 Dietary Guidelines for Americans, citing concerns over conflicts of interest and a lack of transparency in the development process.

Cervical cancer screening rates are increasing, yet significant disparities persist among Native American, Alaska Native, Native Hawaiian, and Pacific Islander populations.

The FDA has granted a supplemental indication for satralizumab to treat thyroid eye disease, marking further expansion in available therapies for this condition.

The twiist Automated Insulin Delivery System has received FDA clearance, providing a new treatment option for adults living with insulin-treated type 2 diabetes.

Brytly, an over-the-counter eye drop containing apraclonidine, has been approved for the treatment of eye redness in patients aged 12 and older.

New clinical findings indicate that women with inflammatory bowel disease (IBD) generally experience high success rates with fertility treatments regardless of prior surgery or disease activity.

Sunscreen products containing the filter bemotrizinol have hit US store shelves, offering improved UVA protection and a more favorable texture for consumers.

The All-Party Parliamentary Group (APPG) on Pharmacy is calling on the government to release an overdue response regarding proposals to allow pharmacists to substitute medication strengths and formulations.